LIFESTEM LAUNCHES PROJECT TO DEVELOP STEM CELL DELIVERY DEVICE

CalbaTech, a life sciences company concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, announced that its wholly owned subsidiary, LifeStem, launched a major project to develop its Stem Cell Delivery Device.

"Most stem cell research and development currently is concentrated on cellular therapeutics as opposed to the delivery of stem cells," said LifeStem President Dan Fulkerson. "Our subsidiary is confident that stem cell research, its applications and specifically the necessary targeted delivery, will expand exponentially in the near future."

LifeStem's stem cell delivery device is a patent pending proprietary system for the regeneration of cardiac muscle post myocardial infarction. It is a disposable sheath placed over a rigid fiber optic endoscope, allowing diagnostic and delivery mechanisms. This provides the ability to detect dead and diseased cardiac tissue with the precision delivery of stem cells, thus promoting regeneration.